Delivery Order SPE2DB22D3102-SPE2DB24FL2DP
Award Date
7/24/24
Potential Completion Date
7/25/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,294.60, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet units to the Defense Logistics Agency (DLA). The $2,840.23 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of November 17, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet medication to the Defense Logistics Agency (DLA). The $2,494.96 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of the parent company Cencora, Inc. This $7,010.86 delivery order was awarded on April 27, 2023, with a completion date of April 28, 2023. The contract has a firm fixed price pricing type and is not designated with any set-aside requirements, indicating open competition....
This federal contract award is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has an award value of $1,951.09 and an ultimate completion date of August 23, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not set aside for...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablets to the Defense Logistics Agency (DLA). The $3,546.28 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of Micardis HCT 80-12.5 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,346.30 and a final completion date of December 5, 2023. It is a delivery order contract with a firm fixed price pricing type. This contract is not designated with any set-aside requirements,...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet units to the Defense Logistics Agency (DLA), a defense agency. The $1,666.42 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 22, 2023, with a completion date of May 23, 2023. This contract is a delivery order under a larger $999,999,999 indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet units to the Defense Logistics Agency (DLA). The $1,057 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award has an ultimate completion date of March 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet units to the Defense Logistics Agency (DLA), a defense agency. The $2,865.39 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a performance period running through February 15, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...